Related Experiment Video
Updated: May 23, 2025

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Exploring novel non-opioid pathways and therapeutics for pain modulation
Isabella Alessi1, Kaysie L Banton2,3, Sliter J4
1College of Osteopathic Medicine, Rocky Vista University, Centennial, CO, USA.
Abstract:
The opioid crisis has highlighted the urgent need for alternative pain management strategies. This review explores novel non-opioid targets and pathways involved in pain modulation, highlighting advancements in understanding and therapeutic potential. Pain, a multifaceted phenomenon with nociceptive, neuropathic, and inflammatory components, involves intricate molecular signaling cascades. Key pathways reviewed include voltage-gated sodium channels (Nav1.7, Nav1.8, Nav1.9), inflammasome complexes (NLRP3), the kynurenine pathway, prostaglandins, and bradykinin-mediated signaling. Emerging therapeutics such as selective Nav channel blockers, NLRP3 inhibitors, kynurenine pathway modulators, EP receptor antagonists, and bradykinin receptor antagonists offer promising alternatives to opioids. Despite challenges in clinical translation, these developments signal a paradigm shift in pain management, with precision-focused therapies poised to address unmet needs. This review emphasizes the importance of integrating molecular insights into the development of safer, more effective analgesics, setting the stage for transformative advancements in non-opioid pain relief.
Insights
The opioid crisis necessitates new pain relief. This review details non-opioid targets like sodium channels and inflammasomes, offering safer alternatives for effective pain management.
Area of Science:
- Neuroscience and Pharmacology
- Molecular Biology and Immunology
Background:
- The ongoing opioid crisis underscores the critical need for alternative pain management strategies.
- Pain is a complex condition with nociceptive, neuropathic, and inflammatory origins, driven by intricate molecular signaling.
Purpose of the Study:
- To review novel non-opioid targets and pathways in pain modulation.
- To highlight advancements in understanding and the therapeutic potential of these targets.
Main Methods:
- Literature review of key pain pathways including voltage-gated sodium channels (Nav1.7, Nav1.8, Nav1.9), inflammasome complexes (NLRP3), kynurenine pathway, prostaglandins, and bradykinin signaling.
- Analysis of emerging therapeutics targeting these pathways.
Main Results:
- Identified selective Nav channel blockers, NLRP3 inhibitors, kynurenine pathway modulators, EP receptor antagonists, and bradykinin receptor antagonists as promising non-opioid analgesics.
- Highlighted the therapeutic potential of targeting these molecular pathways for pain relief.
Conclusions:
- Developments in non-opioid targets signal a paradigm shift towards precision pain management.
- Integrating molecular insights is crucial for developing safer, more effective analgesics and transformative pain relief strategies.
More Related Videos
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
09:02Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Pain
Nociception